BRIEF published on 04/22/2026 at 22:10, 4 months 24 days ago Abivax to Present Data on Obefazimod at Digestive Disease Week® Abivax Obefazimod Ulcerative Colitis Phase 3 Clinical Trials DDW 2026
PRESS RELEASE published on 04/22/2026 at 22:05, 4 months 24 days ago Abivax to Present Data on Obefazimod at Digestive Disease Week® Abivax to present data on Obefazimod at Digestive Disease Week, showcasing efficacy, safety, and patient outcomes from Phase 3 ABTECT program and preclinical anti-fibrotic models Abivax Obefazimod Clinical Trials Digestive Disease Week Inflammatory Bowel Disease
BRIEF published on 04/20/2026 at 22:10, 4 months 26 days ago Abivax: Annual General Meeting scheduled for May 11, 2026 Biotechnology Abivax Obefazimod General Assembly Preparatory Documents
BRIEF published on 04/20/2026 at 22:10, 4 months 26 days ago Abivax Prepares for General Meeting with Document Release Biotechnology Abivax Ulcerative Colitis General Meeting Preparatory Documents
PRESS RELEASE published on 04/20/2026 at 22:05, 4 months 26 days ago Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents Abivax informs shareholders about the Annual Ordinary and Extraordinary General Meeting on May 11, 2026, in Paris, providing access to preparatory documents Shareholders Abivax General Meeting Clinical-stage Biotechnology Preparatory Documents
BRIEF published on 04/17/2026 at 15:48, 4 months 29 days ago JP Morgan Chase & Co. crosses the 5% threshold in ABIVAX Voting Rights Abivax Threshold Crossing JP Morgan Indirect Ownership
BRIEF published on 04/17/2026 at 10:42, 4 months 29 days ago JP Morgan Chase & Co. reduces its stake in ABIVAX Euronext Paris Voting Rights Abivax Threshold Crossing JP Morgan
BRIEF published on 04/08/2026 at 12:17, 5 months 8 days ago Abivax presents the results of the ABTECT trial Abivax Obefazimod Ulcerative Colitis Clinical Trial Tolérance
BRIEF published on 04/01/2026 at 22:10, 5 months 15 days ago Abivax submits its financial reports to French and American regulators AMF Abivax Financial Reports Regulation DRY
BRIEF published on 04/01/2026 at 22:10, 5 months 15 days ago Abivax Files Financial Documents with French and U.S. Regulatory Bodies Abivax Financial Reports Annual Report Universal Registration Document Regulatory Agencies
Published on 09/16/2026 at 23:45, 6 hours 44 minutes ago Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 8 hours 59 minutes ago Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 13 hours 34 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 15 hours 29 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 16 hours 29 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/17/2026 at 04:25, 2 hours 3 minutes ago Zhou Jianjun from Huawei: Building a Grid-Interactive AIDC Solution to Maximize Tokens Per Watt
Published on 09/16/2026 at 23:45, 6 hours 43 minutes ago WESCAN GOLDFIELDS COMMENCES UAV MAGNETIC AND LIDAR SURVEYS AT MUNRO LAKE PROJECT
Published on 09/16/2026 at 22:33, 7 hours 55 minutes ago EQS-Adhoc: Bilfinger adjusts outlook for 2026 and resolves program “Agile”
Published on 09/16/2026 at 21:15, 9 hours 13 minutes ago Gastech 2026 in Bangkok Converts Global Energy Ambition into Billions of Dollars in Deals
Published on 09/16/2026 at 20:27, 10 hours 1 minute ago EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million
Published on 09/16/2026 at 17:45, 12 hours 44 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 23 hours 29 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 12 hours ago Report on the Combined General Meeting of the 10th of September 2026
